Forbes Asia – June 2026

Forbes Asia – June 2026

Summary

Forbes Asia's June 2026 issue names 300 innovators across 10 industries in the 30 Under 30 Asia Class of 2026 — the 11th edition of the region's definitive young-talent ranking.

Volume 22 number 3 runs with the annual 30 Under 30 Asia list (p.18), edited by Rana Wehbe Watson, covering innovators from agriculture to venture capital. The Profile features David Beckham's business evolution in "Bank It Like Beckham" (p.32), where Maneet Ahuja tracks the former footballer's transition from endorser to franchise owner and brand equity holder. Taiwan's 50 Richest (p.39) opens with "Chip Charge" as semiconductor fortunes surge on AI demand, while Japan's 50 Richest (p.48) titles its section "AI Bounty" — both lists reflect the AI-driven wealth boom reshaping Asian billionaire ranks. Anthem Biosciences appears in "Journey of Discovery" (p.52), tracing the Indian contract research firm's bet on biologics manufacturing. The Trend piece uncovers "The Shadow IPO Market" (p.63), where private-company shares trade on secondary platforms before official listings. The Immigrant Journey (p.69) quantifies immigrant-founded companies' contribution to the US economy.

Steve Forbes opens Fact & Comment with "Toxic Politics." The Thoughts column closes on "Birthdays." The issue provides a comprehensive snapshot of who is building Asia's next generation of companies — and who is funding them.

—————

Content Guide

▸ Cover Feature / The List

p.18 · Forbes 30 Under 30 Asia Class of 2026
The 11th annual list profiles 300 young innovators across 10 categories including finance, healthcare, consumer tech, and media. Each entry includes founding year, funding raised, and revenue bracket. HR teams and venture scouts use this as a pre-vetted talent and deal pipeline for the region.

▸ Profiles

p.32 · Bank It Like Beckham
Maneet Ahuja traces David Beckham's business arc: from Manchester United endorser to Inter Miami co-owner to his own brand-equity firm. The article cites his personal-brand valuation at $680 million and breaks down revenue streams by licensing, equity, and appearance fees.

p.52 · Journey Of Discovery
Anthem Biosciences, an Indian contract research and manufacturing organization, bets on biologics. The company invested $200 million in a dedicated mammalian cell-culture facility. Anyone tracking the India pharma manufacturing shift can use the capacity numbers as a benchmark.

▸ Rich Lists

p.39 · Chip Charge
Taiwan's 50 Richest list reflects the AI semiconductor boom. Foxconn founder Hon Hai's wealth leads, but chip-design and packaging firms produced the fastest gainers. The sector-tagged list helps investors identify non-obvious Taiwan tech exposure.

p.45 · Tooling Up
A companion profile within Taiwan's 50 Richest coverage. A machine-tool manufacturer pivoted to semiconductor equipment parts; revenue grew 3x in 24 months. Supply-chain managers scouting Taiwan's precision-engineering base get a short list.

p.48 · AI Bounty
Japan's 50 Richest list shows SoftBank's Masayoshi Son returning to the top as Arm's valuation surged. New names include AI software founders from Tokyo-based startups. The list is useful for Japan entry research.

▸ The Trend / Investing

p.63 · The Shadow IPO Market
Phoebe Liu reports on secondary trading platforms where private-company shares change hands before official IPOs. She cites Forge and Hiive as primary platforms. Accredited investors accessing pre-IPO allocations can use the liquidity-premium data table.

p.69 · The Immigrant Journey
Giacomo Tognini and Luisa Kroll quantify the contribution of immigrant-founded companies to the US economy. Immigrant-founded Fortune 500 companies generated $6.7 trillion in revenue. Policy-focused readers get the data package for advocacy arguments.

—————

Editor's Take

The 30 Under 30 Asia list is the anchor here — it is the most comprehensive talent pipeline published in the region each year, and this 11th edition benefits from a decade of methodology refinement. The Taiwan and Japan rich lists are essential for anyone tracking the AI wealth redistribution across Asian markets. The Beckham profile is better than expected: it has actual valuation numbers and revenue stream breakdowns rather than sports nostalgia. The weakest piece is "Journey of Discovery" on Anthem Biosciences, which reads as a company-commissioned overview without any critical lens. The Shadow IPO Market feature is genuinely useful for accredited investors. Overall, this issue serves two distinct audiences well — venture talent scouts and Asia wealth-trackers — without compromising either.

Strengths
• 30 Under 30 Asia list with funding and revenue brackets
• Beckham profile with $680 million brand valuation
• Taiwan and Japan rich lists sector-tagged for AI exposure

Weaknesses
• Anthem Biosciences piece lacks independent reporting
• Shadow IPO feature could use more trade-off discussion on valuation gaps

Verdict: Recommended — The definitive Asia young-talent ranking combined with AI-driven wealth data makes this a dual-audience winner.

Disclaimer: All original content on this site is protected; reproduction without written consent is prohibited. We do not host files and only provide automated links to publicly available resources. If you believe any content infringes your rights, please contact us for prompt removal or resolution. We respect copyright and are committed to cooperating with rights holders.